GMDA

Gamida Cell Ltd
1.75
0.06 (3.55%)

Gamida Cell Ltd. (GMDA) Fundamentals

Gamida Cell Ltd is a biopharmaceutical company involved in developing advanced cell therapies with the potential to cure cancer and rare, serious hematologic diseases. The company's product includes NiCord that is a cell therapy based on NAM-expanded cord blood designed to enhance and expand the life-saving benefits of hematopoietic stem cell transplant. It is also developing GDA-201 which is innate immunotherapy of expanded natural killer cells, for the treatment of refractory non-Hodgkin lymphoma and multiple myeloma. It is developing a diverse pipeline of cell therapies using its proprietary NAM technology that has the potential to bring life-saving treatment options to patients.
SHARE INFORMATION
Market Cap$ 126,045,314
Shares Outstanding74,583,026
Float64,637,040
Percent Float86.66%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -1.52
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions53
Institutional Holdings Date2023-01-31
Institutional Bought Previous 3 Months156,954
Institutional Holdings Percent15.8%
Institutional Sold Previous 3 Months716,213
Insider Holdings Date2023-01-31
Insider Bought Previous 3 Months60,500
Insider Holdings Percent1.2
Insider Sold Previous 3 Months-
Insider Shares Owned858,550
TRADING INFO
52 Week High$ 4.72
52 Week Low$ 1.10
52 Week High Change$ -48.16
21 Day Moving Average$ 1.5757
21 Day Extended Moving Average$ 1.5751
50 Day Moving Average$ 1.4402
50 Day Extended Moving Average$ 1.5505
200 Day Moving Average$ 1.9573
200 Day Extended Moving Average$ 2.0896
10 Day Average Volume368,276
20 Day Average Volume401,594
30 Day Average Volume472,529
50 Day Average Volume484,031
Alpha-0.023693
Beta1.6612
Standard Deviation0.240263
R20.153997
7 Day Price Change$ 0.09
7 Day Percent Change5.63%
21 Day Price Change$ 0.14
21 Day Percent Change9.03%
30 Day Price Change$ 0.28
30 Day Percent Change19.86%
Month to Date Price Change$ 0.09
Month to Date Percent Change5.63%
Quarter to Date Price Change$ 0.40
Quarter to Date Percent Change31.01%
180 Day Price Change$ -0.47
180 Day Percent Change-21.76%
200 Day Price Change$ 0.12
200 Day Percent Change7.64%
Year to Date Price Change$ 0.40
Year to Date Percent Change31.01%

Gamida Cell Ltd. (GMDA) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book9.20
Total Debt To Equity5.80
Int Coverage-29.30
Current Ratio2.80
Leverage Ratio7.50
Quick Ratio2.70
Long Term Debt To Capital0.85
VALUATION MEASURES
PE Ratio-1.20
Enterprise Value$ 142,057,483
Price to Sales0.00
Price to Free Cash-2.20
PE High Last 5 Years0.00
Price To Book9.20
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book9.20
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-57.58
Return on Equity-270.36
Return on Capital-74.63

Gamida Cell Ltd. (GMDA) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorKost Forer Gabbay & Kasierer
CEOAbigail L. Jenkins
Emplyoees168
Last AuditUQ
CIK0001600847
IndustryBiotechnology
SectorHealthcare
NAICS-
CONTACT INFO
Address5 Nahum Heftsadie Street
P.O. Box 34670
Jerusalem, 91340
Websitehttps://www.gamida-cell.com
Facsimile+972 26595616
Telephone+972 26595666
Email-


Your Recent History
NASDAQ
GMDA
Gamida Cel..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.